(VIANEWS) - Hamilton Lane Incorporated (HLNE), Quidel (QDEL), Lantheus Holdings (LNTH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Hamilton Lane Incorporated (HLNE)
21.6% sales growth and 31.27% return on equity
Hamilton Lane Incorporated, an investment company, specializes in fund-of-fund investments. The company offers the following services: Separate accounts that are customized to every client; specialized strategies (funds-of-funds and secondaries, coinvestments, Taft-hartley distribution management); and advisory relationships. These include due diligence, strategic portfolio planning and monitoring. The firm makes direct investments in mature, early and mid-stage companies as well as in growth equity and emerging growth. It also invests in distressed debt. Later stage turnarounds and bridge funding, mezzanine and middle-market buyouts. It invests in fund of funds investments. This includes mezzanine and venture capital, private investment, turnaround, secondary investors, real estate, special situation funds, and private equity. It invests in real property investments. The firm also invests in healthcare, education and natural resources. It is also involved with financial empowerment and cleantech. The firm invests in the private equity markets of North America, Latin America and United States. It also has investments in Western Europe, Asia, Japan, Australia, Middle East, Africa, United Kingdom, Asia and Japan. It prefers to invest between $1 million and $100 million in companies. The firm prefers to own a majority of companies. Hamilton Lane Incorporated, which was established in 1991, is located in Philadelphia, Pennsylvania. It also has additional offices in Europe, North America and Asia.
Earnings per Share
Hamilton Lane Incorporated's trailing twelve-month EPS is $3.67.
PE Ratio
Hamilton Lane Incorporated's trailing 12-month price-to-earnings ratio is 17.87. The purchaser of the shares is investing $17.87 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a company, was 31.27%.Moving Average
Hamilton Lane Incorporated's value is under its 50-day moving average of $68.47 and under its 200-day moving average of $68.93.2. Quidel (QDEL)
20.9% sales growth and 31.79% return on equity
QuidelOrtho Corporation is a company that develops and produces diagnostic testing technology across a range of healthcare needs. It operates via Labs, Transfusion Medicine and Point-of-Care business units. Labs is a business unit that provides laboratory equipment and testing for clinical chemistry. These instruments measure the target chemicals present in body fluids and are used to evaluate health, and provide diagnostic services. Transfusion Medicine offers immunohematology tools and blood testing to confirm patient-donor compatibility for transfusions. It also provides donor screening and instruments for screening blood for potential infectious diseases. Point-of-Care provides rapid results in a variety of settings. The Molecular Diagnostics unit provides polymerase chain reactions thermocyclers, analyzers, and amplification system. It sells products direct to the end user through its direct sales force and through a network distributors. The company's products are available for professional use at hospitals, clinics and reference labs, physician offices and universities. The company operates internationally, in North America and Europe as well as the Middle East, Africa, China and Middle East. It was established in 1979 in San Diego, California.
Earnings Per Share
As for profitability, Quidel has a trailing twelve months EPS of $18.6.
PE Ratio
Quidel has a trailing twelve months price to earnings ratio of 4.63. Meaning, the purchaser of the share is investing $4.63 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.79%.Yearly Top and Bottom Value
Quidel's stock is valued at $86.14 at 10:22 EST, way below its 52-week high of $120.61 and way above its 52-week low of $66.88.
Volume
Today's last reported volume for Quidel is 33655 which is 94.81% below its average volume of 649645.
Sales Growth
Quidel's sales growth is 41.2% for the current quarter and 20.9% for the next.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is a negative 86.2% and a negative 82.7%, respectively.3. Lantheus Holdings (LNTH)
20.8% sales growth and 18.82% return on equity
Lantheus Holdings, Inc. designs, produces, and markets diagnostic and therapeutic products and agents that aid clinicians with the treatment and diagnosis of cancer and heart disease. DEFINITY is a microbubble-based ultrasound enhancing agent that can be used to examine the heart. TechneLite allows for the assessment of pulmonary function. Neurolite can identify areas in the brain where blood flow is reduced or blocked due to stroke. Cardiolite injectable Tc99m-labeled imaging agents. RELISTOR treats opioid-induced constipation. AZEDRA is a radiotherapeutic that can be used to treat both adult and children patients. The Automated Bone Scan Index calculates prostate cancer's disease burden by quantifying hotspots in bone scans. Cobalt (Co 57) is a non-pharmaceutical radiation chemical. Thallium201 is used to diagnose cardiovascular disease. Gallium67 detects various cancerous tumors and infections. Quadramet treats severe bone pain caused by osteoblastic metastatic bone lesion. PyL is also developed by the company. The company serves hospitals, clinics and groups as well as PET manufacturing plants, integrated delivery networks, radiopharmacies, and PET manufacturing facilities. Strategic partnerships include NanoMab Technology Limited, Bausch Health Companies, Inc., GE Healthcare Limited, Curium, Bayer AG, Cyn Inc., ROTOP, FUJIFILM Toyama Chemical Co. Ltd., Regeneron Pharmas, Inc., and POINT Biopharma USA Inc. Company was established in 1956. It is located in North Billerica in Massachusetts.
Earnings per Share
Lantheus Holdings' trailing 12 month EPS is $1.43.
PE Ratio
Lantheus Holdings' trailing 12 months earnings to price ratio is 33.9. The purchaser of the shares is therefore investing $33.9 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 18.82%.Earnings Before Interest, Taxes, Depreciation, and Amortization
Lantheus Holdings's EBITDA is 50.14.
Sales Growth
Lantheus Holdings has experienced a sales increase of 88.7% in the most recent quarter, and 20.8% the following.
Annual Top and Bottom Value
At 10:22 EST Lantheus Holdings shares are valued at $48.48. This is way lower than the 52-week high at $87.47, and much higher than the 52-week low at $23.51.
Moving Average
Lantheus Holdings's value is way below its 50-day moving average of $57.41 and way under its 200-day moving average of $66.09.4. John B. Sanfilippo & Son (JBSS)
11.6% sales growth and 23.36% return on equity
John B. Sanfilippo & Son, Inc., along with JBSS Ventures, LLC, process and distribute tree nuts in the United States. Raw and processed nuts include almonds and pecans as well as peanuts and English walnuts. You can also find peanut butter in different sizes, varieties, snack and trail mix, salad toppings and snack bites; chocolate and yogurt coated products, baking ingredients, bulk food products, sunflower kernels and pepitas; almond butter, cashew butter and candy and confections; as well as various toppings for yogurt and ice cream. The company also has a retail shop. It sells its products under several brands including the Sunshine Country, Orchard Valley Harvest and Squirrel brands. Through a network independent distributors and brokers, the company serves wholesalers and retailers as well as commercial ingredients and contract packaging customers. John B. Sanfilippo & Son, Inc. was established in 1959. It is based in Elgin, Illinois.
Earnings Per Share
As for profitability, John B. Sanfilippo & Son has a trailing twelve months EPS of $5.01.
PE Ratio
John B. Sanfilippo & Son has a trailing twelve months price to earnings ratio of 15.76. Meaning, the purchaser of the share is investing $15.76 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.36%.Moving Average
John B. Sanfilippo & Son's worth is below its 50-day moving average of $82.88 and higher than its 200-day moving average of $78.05.Earnings Before Interest, Taxes, Depreciation, and Amortization
John B. Sanfilippo & Son's EBITDA is 34.75.
Sales Growth
John B. Sanfilippo & Son's sales growth is 24.7% for the current quarter and 11.6% for the next.
Volume
Today's last reported volume for John B. Sanfilippo & Son is 46868 which is 0.35% below its average volume of 47037.
5. Eagle Materials (EXP)
9.8% sales growth and 34.15% return on equity
Eagle Materials Inc. and its subsidiaries produce and supply heavy and light construction materials and materials for oil and gas extraction in the United States. The company operates five divisions: Cement and Concrete and Aggregates; Gypsum Wallboard; Recycled Paperboard; and Oil and Gas Proppants. It is involved in mining limestone to make Portland cement. The company also manufactures and sells recycled paperboard to the gypsum industry as well as other paperboard converters. It also provides containerboard and lightweight packaging grades products. The company also sells ready-mix concrete, mining, extraction, production and sale aggregates. This includes crushed stones and gravel. It also mines and sells sand used for hydraulic fracturing such as fracsand. The company's products can be used for commercial or residential construction, as well as public projects such roads, bridges, expansions, repairs, and maintenance. Centex Construction Products, Inc. was the company's previous name. In January 2004, Eagle Materials, Inc. took over that title. Eagle Materials Inc. was established in 1963. It is located in Dallas, Texas.
Earnings per Share
Eagle Materials' trailing 12 month EPS is $10.82.
PE Ratio
Eagle Materials' trailing 12-month price-earnings ratio is 13.27. The purchaser of the shares is therefore investing $13.27 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 34.15%.Revenue Growth
Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 2.04B for the twelve trailing months.
Sales Growth
Eagle Materials saw a 15.7% increase in sales for its current quarter, and 9.8% the following.
Dividend Yield
Morningstar, Inc. has stated that the next dividend payment will be made Dec 14th 2022. The forward dividend rate for 2020 is estimated at 1 while the forward dividend yield is estimated to be 0.7%.
Yearly Top and Bottom Value
Eagle Materials's stock is valued at $143.54 at 10:22 EST, way under its 52-week high of $162.04 and way above its 52-week low of $101.98.
6. Sherwin (SHW)
5.8% sales growth and 73.29% return on equity
Sherwin-Williams Company designs, produces, distributes and sells paints and coatings to commercial, professional and residential customers. The Americas Group and Consumer Brands Group are its three main segments. The Performance Coatings Group is the third. The Americas Group offers paints and coatings for architects, protective and marine applications, and OEM products finishes. It also has related products and products that can be used by industrial and architectural paint contractors and homeowners. Consumer Brands Group supplies an assortment of private and branded architectural paints and varnishes as well as industrial and wood finishing products. It also offers applicators and corrosion inhibitors. Performance Coatings Group develops and markets industrial coatings that are suitable for finishing wood and other general industrial uses, as well as protective, marine, protective, packaging, colorants, coatings and coils. Through its branch offices and directly sales personnel, it serves dealers, jobbers and licensees as well as other distributors. It has operations in North America and South America as well as Europe, Asia and the Caribbean. It had approximately 5,000 stores and other facilities that it owned as of February 17, 2022. Cleveland is the home of Sherwin-Williams Company, which was established in 1866.
Earnings Per Share
As for profitability, Sherwin has a trailing twelve months EPS of $7.74.
PE Ratio
Sherwin has a trailing twelve months price to earnings ratio of 31.86. Meaning, the purchaser of the share is investing $31.86 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 73.29%.